EUVIMEDEUVIMED entdecken
Crossref

Cardiovascular outcomes under hypothetical blood‐pressure‐lowering intervention in type 2 diabetes: A target trial emulation

Xue Tian iD, Shouling Wu iD, Xue Xia iD, Qin Xu iD, Shuohua Chen, Anxin Wang iD, Ruile Fang

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70472 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Xue Tian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Antihypertensive Agents, Hypertension, Cardiovascular Diseases. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The effective target for systolic blood pressure (SBP) control in patients with diabetes was inconsistent. We evaluated the emulated effect of maintaining SBP below clinical thresholds on the risk of cardiovascular disease (CVD) and all‐cause mortality. Materials and Methods This study included 4264 patients with type 2 diabetes from the Kailaun study. We implemented the parametric g‐formula to simulate the hypothetical interventions on reducing SBP below 140, 130 and 120 mmHg over time, accounting for time‐varying confounding, reporting risk ratio (RR) and number needed to treat (NNT) for 10‐year risk of CVD and all‐cause mortality.

Results

Maintaining SBP below 140, 130 and 120 mmHg was associated with an 18%, 24%, and 31% relative risk reduction in the risk of CVD, with the RR (95% confidence interval [CI]) of 0.82 (0.75–0.88), 0.76 (0.69–0.86), and 0.69 (0.58–0.84), and the NNT of 32, 24, and 19, respectively, compared to no intervention. However, the benefits in reducing the risk of all‐cause mortality did not reach a significant level with maintaining SBP below 140 and 130 mmHg, with the RR (95% CI) of 0.98 (0.93–1.06) and 1.04 (0.95–1.12), respectively. The risk of all‐cause mortality significantly increased 15% with maintaining SBP ≤120 mmHg (RR, 1.15; 95% CI, 1.02–1.32). Subgroup analyses showed that maintaining SBP ≤120 mmHg tended to bring more harms than benefits in patients aged ≥60 years or without antihypertensive agents.

Conclusion

Among Chinese patients with type 2 diabetes, maintaining SBP ≤120 mmHg may not be an optimal target, in terms of the risk–benefit association of CVD and all‐cause mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Antihypertensive AgentsHypertensionCardiovascular DiseasesDiabetic AngiopathiesHumansFemaleMiddle AgedMaleAgedBlood PressureChina

Stichwörter der Autor:innen

SBP lowering interventionall‐cause mortalitycardiovascular diseasediabetestarget trial emulation

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Clinical Epidemiology and Clinical Trial, Capital Medical University, Beijing, China.
  • Department of Epidemiology, Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  • Department of Cardiology, Kailuan Hospital, North China University of Science and Technology, Tangshan, China.

ORCID-Profile: Xue Tian, Shouling Wu, Xue Xia, Qin Xu, Anxin Wang

Zitieren

APA

Tian, X., Wu, S., Xia, X., Xu, Q., Chen, S., Wang, A., & Fang, R. (2026). Cardiovascular outcomes under hypothetical blood‐pressure‐lowering intervention in type 2 diabetes: A target trial emulation. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70472

Vancouver

Tian X, Wu S, Xia X, Xu Q, Chen S, Wang A, et al. Cardiovascular outcomes under hypothetical blood‐pressure‐lowering intervention in type 2 diabetes: A target trial emulation. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70472

BibTeX
@article{Tian2026,
  author = {Tian, Xue and Wu, Shouling and Xia, Xue and Xu, Qin and Chen, Shuohua and Wang, Anxin and Fang, Ruile},
  title = {Cardiovascular outcomes under hypothetical blood‐pressure‐lowering intervention in type 2 diabetes: A target trial emulation},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70472}
}
Kostenlos starten →